Biotech IPOs Stage A Bit of a Comeback

Abrams, Sandra Lea
September 2005
Investment Dealers' Digest;9/26/2005, Vol. 71 Issue 36, p12
Trade Publication
Reports on the increase in public offerings from biotechnology industries in the U.S. Factors contributing to the increasing trend; Identification of top performing companies in public offerings; Important role of clinical trials in the commercial viability of biotechnology companies.


Related Articles

  • THE IPO 100.  // Investment Dealers' Digest;9/19/2005, Vol. 71 Issue 35, p16 

    Presents charts and graphs depicting the top 100 initial public offerings in the U.S. for the week ended September 14, 2005. Offer price of Enterprise GP Holdings; Percentage change in the deal of Bronco Drilling Co. Inc.; Price of the offering of Medical Properties Trust Inc.

  • IPOs, Dirt-Cheap. Cramer, James J. // New York;11/15/2004, Vol. 37 Issue 40, p30 

    Looks into the initial public stock offerings of companies. Discovery of the fact that deals are being priced at a discount relative to demand; Prices of some of the deals mentioned; Advice of the author regarding the matter.

  • HK companies look West for IPOs. Begum, Husnara // Lawyer;4/5/2004, Vol. 18 Issue 13, p4 

    Reports on trends in the initial public offering (IPO) market in Hong Kong, China as of April 5, 2004. Efforts of Chinese companies to access the U.S. capital markets by doing dual listings in Hong Kong and Nasdaq; Factors that may deter Chinese companies from listing in the U.S.; Implications...

  • Form 10 Offers Alternative to IPO, Reverse Merger Listing. Morrison, Trista // BioWorld Insight;7/25/2011, Vol. 19 Issue 30, p2 

    The article focuses on the Form 10 pathway, which offers alternative to initial public offerings (IPO) to public listing for biotechnology companies with 500 or more stockholders of record. Annette Grimaldi, managing director at BMO Capital Markets Corp., says that they discuss with other...

  • Spy Eyeing Chance For Public Offering. Graves, Brad // San Diego Business Journal;9/27/2004, Vol. 25 Issue 39, p1 

    The article reports that Spy Optic Inc., a sunglass and goggle maker, is palling to go public. The company described plans for a $21 million initial public offering in a statement filed with the U.S. Securities and Exchange Commission on September 15, 2004. The date of the start of its stock...

  • DAMIANI IPO KICKS OFF. Kaiser, Amanda // WWD: Women's Wear Daily;10/29/2007, Vol. 194 Issue 91, p17 

    This article states that Italian jeweler Damiani SpA began an initial public offering Friday that could generate as much as 150.8 million euros, or $215.4 million at current exchange. Damiani family members are selling 26.36 million shares, or about 31.9 percent of their company, in the offer....

  • IPOs: Once Hot, Now Not. Osterfelt, Susan // DM Review;Jun2003, Vol. 13 Issue 6, p65 

    Discusses the advantages and disadvantages of initial public offerings. Factors that contribute to the decline in the number of companies that go public; Benefits of being traded publicly; Costs to be incurred by a company once it decides to go public.

  • Industries Qatar IPO launches big IPO.  // MEED: Middle East Economic Digest;5/9/2003, Vol. 47 Issue 19, p19 

    Announces the launching of the initial public offering (IPO) of Industries Qatar. Details of the company's formation; Face value of the company's shares; Amount expected to be raised from the IPO.

  • BofA Taps Mixon For New Role.  // High Yield Report;2/28/2005, Vol. 16 Issue 8, p8 

    The article presents news related the sales growth of the U.S. high yield market. Bank of America has announced that Arrington Mixon will become the bank's new global head of credit syndicate. Mixon will be responsible for enhancing the integration of the bank's syndicate functions across loans...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics